- Recent Perspective of Metformin
-
Hong S
- KMID: 2526185
- J Korean Diabetes.
- 2021 Jun;22(2):85-90.
- doi: 10.4093/jkd.2021.22.2.85
Metformin has been used clinically more than 60 years in type 2 diabetes as the first-line drug for treatment. Metformin has been prescribed in more than 80% of Korean patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Perspective on Thiazolidinedione
-
Kim WJ
- KMID: 2526187
- J Korean Diabetes.
- 2021 Jun;22(2):97-104.
- doi: 10.4093/jkd.2021.22.2.97
Thiazolidinedione (TZD) is an insulin sensitizer that improves insulin resistance in the adipose tissue, liver, and muscles and has a pancreas-protective effect while inhibiting gluconeogenesis. Its other advantages include a... -
- CITED
-
- Close
- SHARE
-
- Close
- Blood Sugar Management Related to Home Meal Replacement and Delivery Meal Services among Patients with Diabetes Mellitus
-
Noh MY
- KMID: 2526192
- J Korean Diabetes.
- 2021 Jun;22(2):142-146.
- doi: 10.4093/jkd.2021.22.2.142
Dietary management is an important factor in glycemic control among patients with diabetes mellitus. However, the range of food choices in diabetic diets is limited, increasing the amount of effort... -
- CITED
-
- Close
- SHARE
-
- Close
- COVID-19, Home Training for Patients with Diabetes Mellitus
-
Kim H
- KMID: 2526183
- J Korean Diabetes.
- 2021 Jun;22(2):71-76.
- doi: 10.4093/jkd.2021.22.2.71
Due to the coronavirus disease 2019 (COVID-19) pandemic, people's physical activity has declined by 35% because their time spent at home has increased. Decreased physical activity can increase both the... -
- CITED
-
- Close
- SHARE
-
- Close
- Diabetes in Adolescence, Appropriate Transition to Adult Clinic
-
Lee J, Kim JH
- KMID: 2526184
- J Korean Diabetes.
- 2021 Jun;22(2):77-84.
- doi: 10.4093/jkd.2021.22.2.77
As the prevalence of diabetes in children and adolescents increases, the transition of diabetes care from childhood to adulthood is increasing. During the transition period, the risks for hypoglycemia and... -
- CITED
-
- Close
- SHARE
-
- Close
- A New Paradigm for Care Coordination of Patients with Diabetes Mellitus: Linkage and Application Strategies to Available Resources between the Hospital and the Community
-
Lee HY
- KMID: 2526191
- J Korean Diabetes.
- 2021 Jun;22(2):134-141.
- doi: 10.4093/jkd.2021.22.2.134
Diabetes Mellitus is a chronic disease that can be fatal to high-risk patients infected with the coronavirus. Many diabetic patients have been treated in a hospital setting. The coronavirus era... -
- CITED
-
- Close
- SHARE
-
- Close
- Sulfonylurea, an Update
-
Kim TN
- KMID: 2526188
- J Korean Diabetes.
- 2021 Jun;22(2):105-112.
- doi: 10.4093/jkd.2021.22.2.105
Sulfonylureas (SUs) are widely prescribed in the treatment of type 2 diabetes. Despite the availability of several newer agents, SUs still play an important role in glucose-lowering therapy. However, over... -
- CITED
-
- Close
- SHARE
-
- Close
- Dipeptidyl Peptidase 4 Inhibitor, an Update
-
Lee JH
- KMID: 2526186
- J Korean Diabetes.
- 2021 Jun;22(2):91-96.
- doi: 10.4093/jkd.2021.22.2.91
Dipeptidyl peptidase 4 (DPP4) inhibitors, one of the most prescribed second-line antidiabetic drugs in South Korea, have been available since 2006. Many studies focusing on the safety profiles of DPP4... -
- CITED
-
- Close
- SHARE
-
- Close
- Problem Solving Therapy for Depressed Patients
-
Baek JY
- KMID: 2526193
- J Korean Diabetes.
- 2021 Jun;22(2):147-152.
- doi: 10.4093/jkd.2021.22.2.147
In a recent study, depression showed a negative effect on diabetes management, and comorbid disease was shown to increase risk of depression. This article introduces a problem solving therapy (PST)... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in Sodium Glucose Cotransporter-2 Inhibitors
-
Cho DH
- KMID: 2526189
- J Korean Diabetes.
- 2021 Jun;22(2):113-125.
- doi: 10.4093/jkd.2021.22.2.113
Sodium glucose cotransporter-2 inhibitors (SGLT2i) block SGLT2 in the renal proximal tubule and increase the excretion of glucose into the urine, thereby decreasing serum glucose concentrations. These glucose-lowering effects are... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Updates on Glucagon-Like Peptide 1 Receptor Agonist
-
Kim HJ
- KMID: 2526190
- J Korean Diabetes.
- 2021 Jun;22(2):126-133.
- doi: 10.4093/jkd.2021.22.2.126
Glucagon-like peptide 1 (GLP-1) is a peptide hormone secreted by L cells of the small intestine in response to nutrients. GLP-1 presents a glucose-lowering effect via insulinotropic action on pancreatic... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Autoimmune Pancreatitis Presenting as a Deterioration in Glycemic Control in a Patient with Pre-Existing Type 2 Diabetes
-
Kim SH, Baek CO, Song SK, Kim JH
- KMID: 2526194
- J Korean Diabetes.
- 2021 Jun;22(2):153-159.
- doi: 10.4093/jkd.2021.22.2.153
The present article demonstrates an unusual case of type 1 autoimmune pancreatitis (AIP), focusing on the cause of deterioration in glycemic control and weight loss in a patient with pre-existing... -
- CITED
-
- Close
- SHARE
-
- Close
